23 related articles for article (PubMed ID: 38764133)
1. Effect of Lactobacillus reuteri on Cell Viability and PGE
A Castiblanco G; Yucel-Lindberg T; Roos S; Twetman S
Probiotics Antimicrob Proteins; 2017 Sep; 9(3):278-283. PubMed ID: 28028690
[TBL] [Abstract][Full Text] [Related]
2. Newly Isolated
Kiššová Z; Štofilová J; Mudroňová D; Karaffová V
Front Biosci (Landmark Ed); 2024 May; 29(5):180. PubMed ID: 38812316
[TBL] [Abstract][Full Text] [Related]
3. Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation.
Liu Y; Fatheree NY; Mangalat N; Rhoads JM
Am J Physiol Gastrointest Liver Physiol; 2010 Nov; 299(5):G1087-96. PubMed ID: 20798357
[TBL] [Abstract][Full Text] [Related]
4. Investigating the anti-inflammatory effects of high molecular weight secretions from Limosilactobacillus reuteri PTCC 1655 on LPS-stimulated PMA-differentiated THP-1 cells.
Johari B; Maghsood F; Madanchi H; Moradi M; Kadivar M
J Appl Microbiol; 2021 Aug; 131(2):938-948. PubMed ID: 33377567
[TBL] [Abstract][Full Text] [Related]
5. Heat-killed Lactobacillus reuteri and cell-free culture supernatant have similar effects to viable probiotics during interaction with Porphyromonas gingivalis.
Geraldo BMC; Batalha MN; Milhan NVM; Rossoni RD; Scorzoni L; Anbinder AL
J Periodontal Res; 2020 Apr; 55(2):215-220. PubMed ID: 31691977
[TBL] [Abstract][Full Text] [Related]
6. Microbiota and Probiotics: The Role of Limosilactobacillus Reuteri in Diverticulitis.
Piccioni A; Franza L; Vaccaro V; Saviano A; Zanza C; Candelli M; Covino M; Franceschi F; Ojetti V
Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441008
[TBL] [Abstract][Full Text] [Related]
7. Limosilactobacillus reuteri consumption significantly reduces the total cholesterol concentration without affecting other cardiovascular disease risk factors in adults: A systematic review and meta-analysis.
Liu J; Zhu R; Song J; Sohaib M; Wang S; Mao J; Qi J; Xiong X; Zhou W; Guo L
Nutr Res; 2023 Sep; 117():1-14. PubMed ID: 37419064
[TBL] [Abstract][Full Text] [Related]
8.
Luo Z; Chen A; Xie A; Liu X; Jiang S; Yu R
Front Immunol; 2023; 14():1228754. PubMed ID: 37638038
[TBL] [Abstract][Full Text] [Related]
9. Lactobacillus Reuteri DSM 17938
Saviano A; Brigida M; Migneco A; Gunawardena G; Zanza C; Candelli M; Franceschi F; Ojetti V
Medicina (Kaunas); 2021 Jun; 57(7):. PubMed ID: 34201542
[No Abstract] [Full Text] [Related]
10. Limosilactobacillus reuteri supernatant attenuates inflammatory responses of human gingival fibroblasts to LPS but not to elevated glucose levels.
Janson TM; Ramenzoni LL; Hatz CR; Schlagenhauf U; Attin T; Schmidlin PR
J Periodontal Res; 2024 May; ():. PubMed ID: 38764133
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
